RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE

Aim. To study ramipril effect on parameters of ambulatory blood pressure (BP) monitoring, cardio-vascular remodeling parameters in patients with arterial hypertension (HT) and ischemic heart disease (IHD).Material and methods. 40 patients with HT (stage 1-2) combined with IHD (functional class 1-2)...

Full description

Bibliographic Details
Main Authors:	A. I. Chesnikova, I. N. Koshenskaja, V. P. Terentyev, N. N. Mozhaeva, I. V. Bedareva, L. A. Lavrik, T. V. Zhertovsky
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	arterial hypertension ischemic heart disease hemodynamics cardio-vascular remodeling ramipril
Online Access:	https://www.rpcardio.online/jour/article/view/1091

Similar Items

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
by: B J C Onwubere, et al.
Published: (2007-01-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action
by: Dmitriy Vladimirovich Preobrazhenskiy,, et al.
Published: (2009-03-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE
by: I. I. Sinitsina, et al.
Published: (2016-01-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
by: S. V. Nedogoda
Published: (2016-09-01)

EFFICACY AND SAFETY OF FIXED RAMIPRIL + FELODIPINE COMBINATION IN TREATMENT OF ARTERIAL HYPERTENSION: A RETROSPECTIVE STUDY-FORECAST
by: Ivan Tasić, et al.
Published: (2013-03-01)

EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01)

The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats
by: Lin Yun, et al.
Published: (2018-10-01)

Importance of hemodynamic factors in vascular remodeling of muscular elastic type in arterial hypertension
by: Melnikova L.V.
Published: (2011-03-01)

Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial
by: Gabor Simonyi
Published: (2016-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Clinical efficacy of losartan and ramipril in male patients with hypertension depending on age, uricemia level, and hypertension type
by: V.P. Ivanov, et al.
Published: (2016-12-01)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
by: E. E. Averin, et al.
Published: (2019-01-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
by: M. V. Leonova
Published: (2020-05-01)

Ramipril induced pemphigoid vulgaris
by: Mirza MA, et al.
Published: (2018-09-01)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
by: Omboni S, et al.
Published: (2015-10-01)

The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril
by: A. I. Kochetkov, et al.
Published: (2020-07-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-03-01)

CHANGES IN THE PROOXIDATIVE-ANTIOXIDANT SYSTEM IN SHR SERIES RATS WITH TREATMENT OF HYPOTENSIVE MEDICINES (RAMIPRIL AND CANDESARTANE) IN COMBINATION WITH CORVITIN
by: Aliona Marushchak, et al.
Published: (2020-07-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS
by: Yu. M. Lopatin
Published: (2016-01-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
by: Kateryna Typlynska, et al.
Published: (2023-04-01)

Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter
by: Ya. V. Zemlyaniy
Published: (2014-04-01)

Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective
by: A Aurbach, et al.
Published: (2004-07-01)

Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs)
by: Ahmad Abdul-Wahhab Shahba, et al.
Published: (2022-09-01)

Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis
by: Dolinna Mariia O., et al.
Published: (2020-03-01)

Pengaruh Ramipril terhadap Gambaran Mikroskopis Sel Neuron Otak Tikus Wistar yang Mengalami Edema Otak
by: Muhammad Arief Ansyar, et al.
Published: (2022-05-01)

BEBERAPA TIPE LICHEN PLANUS ORAL YANG DIPICU OLEH RAMIPRIL DAN STRES EMOSIONAL (Laporan kasus)
by: Anandina Irmagita, et al.
Published: (2015-08-01)

Pengaruh Ramipril Terhadap Gambaran Histopatologis Otak Tikus Wistar yang Mengalami Edema Otak
by: Rizka Fitria Husni, et al.
Published: (2021-07-01)

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
by: Ekta Arora, et al.
Published: (2014-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
by: Katarzyna Regulska, et al.
Published: (2021-10-01)

Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization
by: Szpot Paweł, et al.
Published: (2015-06-01)